Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Nexgel Inc

NXGL ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Pharmaceuticals ·

USA Micro Cap Analyst: BUY

Last Close

$0.57

▲ +15.61%

Market Cap $5.21M · Vol 363.41K

Key Metrics

P/E Ratio

N/A

FWD: 4.85

Market Cap

$5.21M

Micro Cap

Div Yield

N/A

EPS Growth

+68.42%

YoY

RSI (14)

65.05

Momentum

Beta

0.90

vs Market

52W High

$2.84

80.11% below

52W Low

$0.33

70.23% above

Volume

363.41K

Avg 29.48K

P/B

2.94

Price-to-book

ROE

N/A

Return on equity

Free Float

85.41%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Nexgel Inc (NXGL) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does NXGL pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+48.68%

+20.47%

+4.24%

-56.54%

YTD

-64.91%

-74.66%

-67.71%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$11.42M
Net Income	$-2,893,000.00
Revenue Growth (YoY)	-5.56%
Gross Margin	39.48%
Operating Margin	-29.35%
Net Profit Margin	-25.33%
ROE	N/A
ROA · ROIC	-26.98% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	4.85
PEG Ratio	N/A
P/S	1.11
P/B	2.94
P/FCF	N/A
EPS Growth	+68.42%
Outstanding Shares	9.23M

Technical Indicators

50-Day SMA	$0.49
200-Day SMA	$1.05
RSI (14)	65.05
Beta	0.90
52-Week High	$2.84
52-Week Low	$0.33

Volume Today	363.41K
Avg Daily Volume (30D)	29.48K
Relative Volume	12.33x
Volatility (10D)	169.98
Volatility (30D)	117.94
Free Float	85.41%

Analyst Consensus

BUY

Current Price $0.57

Mean Target $2.00

52W Low$0.33 52W High$2.84

Current

Target

$0.33 $2.84

Current Analyst target

+253.98% upside potential · 1 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00SK5G0C3

ISINUS65344E1073

CountryUnited States of America

Sub-IndustryPharmaceuticals (NEC)

Earnings DateAug 13, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

NexGel, Inc. is a provider of healthcare, beauty, and over-the-counter products, including high-water-content hydrogels. It is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. The Company operates through two segments: NexGel and CGN. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CGN segment comprises is comprised of the CGN JV used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Silly George. It also holds a portfolio of regenerative biomaterials which include Biovance, Biovance 3L, Natalin, and others.